» Articles » PMID: 37103590

Posterior Wall Isolation Via a Multi-electrode Radiofrequency Balloon Catheter: Feasibility, Technical Considerations, Endoscopic Findings and Comparison with Cryoballoon Technologies

Abstract

Background: Posterior wall (PW) isolation is an important adjunctive ablation target in patients with non-paroxysmal atrial fibrillation (AF). Traditionally performed with point-by-point radiofrequency (RF) ablation, PW isolation has also been performed with different cryoballoon technologies. We aimed at assessing the feasibility of PW isolation with the novel RF balloon catheter Heliostar™ (Biosense Webster, CA, USA).

Methods: We prospectively enrolled 32 consecutive patients with persistent AF scheduled for first-time ablation with the Heliostar™ device. Procedural data were compared with those from 96 consecutive persistent AF patients undergoing pulmonary vein (PV) plus PW isolation with a cryoballoon device. The ratio RF balloon/cryoballoon was 1:3 for each operator involved in the study, aiming at avoiding any imbalance related to different experience.

Results: Single-shot PV isolation was documented in a significantly higher number of cases with the RF balloon technology compared to cryoballoon ablation (89.8% vs. 81.0%; p = 0.02, respectively). PW isolation was achieved with a similar number of balloon applications between the two groups (11 ± 4 with the RF balloon versus 11 ± 2 with the cryoballoon; p = 0.16), but in a significantly shorter time among RF balloon patients (228 ± 72 s versus 1274 ± 277 s with cryoballoon; p < 0.001). Primary safety endpoint occurred in none of the RF balloon patients versus 5 (5.2%) patients in the cryoballoon group (p = 0.33). Primary efficacy endpoint was achieved in all (100%) RF balloon patients versus 93 (96.9%) cryoballoon ones (p = 0.57). Oesophageal endoscopy did not show any signs of thermal lesions in RF balloon patients with luminal temperature rise.

Conclusions: RF balloon-based PW isolation was safe and promoted shorter procedure times compared to similar cryoballoon-based ablation procedures.

Citing Articles

Multielectrode catheter-based pulsed electric field vs. cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis.

Vetta G, Della Rocca D, Parlavecchio A, Magnocavallo M, Sorgente A, Pannone L Europace. 2024; 26(12).

PMID: 39579376 PMC: 11641428. DOI: 10.1093/europace/euae293.


Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison.

Della Rocca D, Marcon L, Magnocavallo M, Mene R, Pannone L, Mohanty S Europace. 2024; 26(1).

PMID: 38245007 PMC: 10823352. DOI: 10.1093/europace/euae016.


Atrial Fibrillation Ablation with a Novel Fully 3D-Mapping-Integrated Multi-Electrode Radiofrequency Balloon Catheter.

Teumer Y, Miesbichler C, Hauke A, Katov L, Bothner C, Pott A J Clin Med. 2024; 13(1).

PMID: 38202216 PMC: 10779570. DOI: 10.3390/jcm13010207.


Implementation of the multielectrode radiofrequency-balloon in real-world clinical practice-operator learning curve and procedural outcome at a high-volume center.

Zylla M, Starrach L, Rahm A, Thomas D, Frey N, Lugenbiel P Front Cardiovasc Med. 2023; 10:1208250.

PMID: 38034374 PMC: 10682364. DOI: 10.3389/fcvm.2023.1208250.


Twenty-five years of research in cardiac imaging in electrophysiology procedures for atrial and ventricular arrhythmias.

Berruezo A, Penela D, Jauregui B, de Asmundis C, Peretto G, Marrouche N Europace. 2023; 25(8).

PMID: 37622578 PMC: 10450789. DOI: 10.1093/europace/euad183.

References
1.
Andrade J, Wells G, Deyell M, Bennett M, Essebag V, Champagne J . Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med. 2020; 384(4):305-315. DOI: 10.1056/NEJMoa2029980. View

2.
Packer D, Mark D, Robb R, Monahan K, Bahnson T, Poole J . Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019; 321(13):1261-1274. PMC: 6450284. DOI: 10.1001/jama.2019.0693. View

3.
Namekata I, Tsuneoka Y, Tanaka H . Electrophysiological and pharmacological properties of the pulmonary vein myocardium. Biol Pharm Bull. 2013; 36(1):2-7. DOI: 10.1248/bpb.b212020. View

4.
Aryana A, Pujara D, Allen S, Baker J, Espinosa M, Buch E . Left atrial posterior wall isolation in conjunction with pulmonary vein isolation using cryoballoon for treatment of persistent atrial fibrillation (PIVoTAL): study rationale and design. J Interv Card Electrophysiol. 2020; 62(1):187-198. PMC: 8210744. DOI: 10.1007/s10840-020-00885-w. View

5.
Verheule S, Tuyls E, van Hunnik A, Kuiper M, Schotten U, Allessie M . Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3(6):590-9. DOI: 10.1161/CIRCEP.109.931634. View